Work

Abstract LB222: Preclinical characterization of IBI3010, a FRα targeting biparatopic antibody-drug conjugate (ADC), for the treatment of FRα expressing tumors

Year: 2025

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.am2025-lb222

Authors: Bo Wang, Jiakai Xing, Shuaixiang Zhou, Weiwei Wu, Min Wu, Rongmei Zuo, Chenchen Zhu, Menghui Zhao, Li Li, Chengjie Cai, Nan Gao, Zhihai Wu, Ninghuan Li, Zeyu Liu, Jinling Xu, Bingliang Chen, Kaijie He

Institution: Innovent Biologics (China)

Language: English

Topic: Monoclonal and Polyclonal Antibodies Research

Subfield: Radiology, Nuclear Medicine and Imaging

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4409820732

Cites:

Cited by: 1

Related to: 10